Serious infections after prostate biopsies appear to be on the rise in the U.S., possibly fueled by antibiotic-resistant bacteria, a new study of elderly men suggests.
More than a million prostate biopsies are done each year on Medicare patients, often to investigate suspicious results from prostate cancer screening. But the majority of those are false alarms, and some doctors worry that many men could be suffering needlessly due to screening.
Just last week, a government-funded expert panel concluded that prostate cancer screening saves few or no lives, but causes harm through treatment or further invasive testing such as biopsies.
Read more:
Infections after prostate biopsy on the rise
